Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction

Journal of Addiction Medicine

Volumn 6, Issue 1, 2012, Pages 18-23

  Peles, Einat ^a   Schreiber, Shaul ^a   Bloch, Miki ^a   Dollberg, Shaul ^a   Adelson, Miriam ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Methadone maintenance treatment; Nicotine; Opiate addiction; Pregnancy outcome; Weight birth

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL DISEASE; NEWBORN; NEWBORN DISEASE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION;

ADULT; BIRTH WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84863701713     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318229bb25     Document Type: Article

References (23)

1. Adelson MO, Hayward R, Bodner G, Bleich A, Gelkopf M, Kreek MJ. Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country. J Mainten Addict 2000;1:5-13.
2. Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Eur Addict Res 2009;15:128-134.
3. Bar-Hamburger R, Shufman E. Changes in psychoactive drug use in Israel from 1990 until 2001. Isr J Psychiatry Relat Sci 2002;39:79-82.
4. Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-termmaternal outcomes. Am J Obstet Gynecol 2002;186:487-495.
5. Burns L, Mattick RP, Lim K, Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007;102:264-270.
6. Cleary BJ, Donnelly J, Strawbridge J, et al. Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis. Addiction 2010;105:2071-2084.
7. Dattel BJ. Substance abuse in pregnancy. Semin Perinatol 1990;14:179-187.
8. Finnengan LP, Kandall SR. Maternal and neonatal effects of alcohol and drugs. LIonw: inson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance Abuse: A Comprehensive Textbook. 3rd ed. Baltimore: Williams & Wilkins; 1997:513-534.
9. Hawks RL. Analytical methodology. NIDA Res Monogr 1986;73:30-42.
10. Hulse GK, Milne E, English DR, Holman CD. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997;92:1571-1579.
11. Kandall R, Albin S, Dreyer E, Comstock M, Lowinson J. Differential effects of heroin and methadone on birth weights. Addict Dis 1975;2:347-355.
12. Klempova D, Okruhlic L. No intrauterine growth retardation in babies of mothers stabilized on methadone before conception and throughout their pregnancies. Heroin Add & Rel Clin Probl 2005;8:25-30.
13. Kramer MS, Lydon J, Séguin L, et al. Stress pathways to spontaneous preterm birth: the role of stressors, psychological distress, and stress hormones. Am J Epidemiol 2009;169:1319-1326.
14. Kreek MJ. Using methadone effectively: achieving goals byapplication oflaboratory, clinical, and evaluation research and by development of innovative programs. NIDA Res Monogr 1991;106:245-266.
15. McCarthy JJ, Leamon MH, Stenson G, Biles LA. Outcomes of neonates conceived on methadone maintenance therapy. J Subst Abuse Treat 2008;35:202-206.
16. McDonald SD, Vermeulen MJ, Ray JG. Risk of fetal death associated with maternal drug dependence and placental abruption: a population-based study. J Obstet Gynaecol Can 2007;29:556-559.
17. Mulder EJ, Robles de Medina PG, Huizink AC, Van den Bergh BR, Buitelaar JK, Visser GH. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev 2002;70:3-14.
18. Peles E, Adelson M. Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. J Addict Dis 2006;25:39-45.
19. Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend 2006;82:211-217.
20. Peles E, Schreiber S, Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel. Drug Alcohol Depend 2010;107:141-148.
21. Sharpe C, Kushel C. Outcomes of infants born to mothers receiving methadone for pain management in pregnancy. Arch Dis Child Fetal Neonatal Ed 2004;89:F33-F36.
22. US Federal Register 21 CRF Part 291 and 42 CRF Part 8 (1-17-2001). Opioid drug in maintenance and detoxification treatment of opiate addiction; final rule.
23. Winklbaur B, Baewert A, Jagsch R, et al. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. implications for treatment. Eur Addict Res 2009;15:150-156.